ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,691,000 | +108.5% | 317,104 | +9.7% | 0.03% | +100.0% |
| Q1 2019 | $7,045,000 | +76.8% | 288,951 | +3.3% | 0.01% | +55.6% |
| Q4 2018 | $3,985,000 | +40.0% | 279,658 | +49.3% | 0.01% | +80.0% |
| Q3 2018 | $2,846,000 | -15.6% | 187,256 | -6.8% | 0.01% | -28.6% |
| Q2 2018 | $3,372,000 | +6.6% | 200,956 | +3.7% | 0.01% | 0.0% |
| Q1 2018 | $3,162,000 | +28.1% | 193,778 | +0.5% | 0.01% | +40.0% |
| Q4 2017 | $2,468,000 | -4.7% | 192,811 | -8.5% | 0.01% | -16.7% |
| Q3 2017 | $2,591,000 | +50.8% | 210,685 | +2.6% | 0.01% | +50.0% |
| Q2 2017 | $1,718,000 | -9.8% | 205,265 | -3.7% | 0.00% | 0.0% |
| Q1 2017 | $1,905,000 | +7.5% | 213,082 | +5.7% | 0.00% | 0.0% |
| Q4 2016 | $1,772,000 | +45.7% | 201,582 | +11.9% | 0.00% | +33.3% |
| Q3 2016 | $1,216,000 | +89.1% | 180,210 | -0.2% | 0.00% | +50.0% |
| Q2 2016 | $643,000 | +34.2% | 180,610 | +11.3% | 0.00% | +100.0% |
| Q1 2016 | $479,000 | -27.9% | 162,207 | +3.0% | 0.00% | -50.0% |
| Q4 2015 | $664,000 | +2.5% | 157,427 | +10.7% | 0.00% | 0.0% |
| Q3 2015 | $648,000 | -34.1% | 142,192 | +4.2% | 0.00% | -33.3% |
| Q2 2015 | $984,000 | -5.3% | 136,508 | -3.1% | 0.00% | 0.0% |
| Q1 2015 | $1,039,000 | +79.8% | 140,923 | +15.4% | 0.00% | +50.0% |
| Q4 2014 | $578,000 | +38.6% | 122,098 | +4.6% | 0.00% | +100.0% |
| Q3 2014 | $417,000 | -21.6% | 116,773 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $532,000 | +8.4% | 116,773 | +11.8% | 0.00% | +100.0% |
| Q1 2014 | $491,000 | -10.4% | 104,440 | -4.6% | 0.00% | -50.0% |
| Q4 2013 | $548,000 | -19.5% | 109,460 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $681,000 | +35.7% | 109,460 | -0.9% | 0.00% | 0.0% |
| Q2 2013 | $502,000 | – | 110,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |